The Academy of Finland granted Johanna Ivaska €2,400,000 in funding for an Academy Professor position
The Academy of Finland granted our Group Leader, Professor Johanna Ivaska €2,400,000 in funding for an Academy Professor position to support research investigating how the stiffness and composition of the tissue surrounding a cancer tumor affect cancer development, drug sensitivity, and cell movement as cancer cells spread in the body.
– The Academy Professorship and the accompanying research funding are a wonderful recognition of my research group and the line of research we have chosen, which focuses on mechanisms,” Ivaska says.
Last updated on October 30, 2025
Recent Posts
- Early-career researchers invited to BioCity Pre-Symposium on 26 August. Registration is now open!Doctoral researchers at BioCity Turku are organising a pre-symposium on 26 August 2026, offering early-career Read moreApril 30, 2026
- 35th BioCity Symposium is arranged 27–28 August 2026. Registration is now open!This year, BioCity Symposium is arranged on-site in Mauno Koivisto Centre, BioCity in 27–28 August Read moreApril 14, 2026
- Turku Protein Core Opens Two New PositionsTurku Protein Core (TuProtCore) is seeking to fill two roles: a Project Specialist in Service Read moreApril 7, 2026
- The Jane and Aatos Erkko Foundation has granted nearly €1 million to support research led by Professor Jukka Westermarck993 000 € was granted to a research project led by our Group Leader Professor Jukka Read moreApril 2, 2026
- Cecilia Sahlgren’s group discovers a new mechanism driving breast cancer progressionOur affiliated research group led by Professor Cecilia Sahlgren at Åbo Akademi University and the InFLAMES Research Read moreMarch 25, 2026
- BioCity Turku asks for proposals for Elias Tillandz publication prize winner during March 2026In the context of the 35th BioCity Symposium “Vision, Expanded” (27-28 August 2026) the twenty-second Read moreMarch 3, 2026